Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | -1.24% | -4.27% | -5.67% |
05-22 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
04-22 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.67% | 493M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.22% | 32.79B | |
+63.62% | 26.23B | |
-21.82% | 14.52B | |
-7.49% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.09% | 8.82B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- Insider Trends: Insider 90-Day Selling Trend Extended at KalVista Pharmaceuticals